Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1996 Feb;34(2):241–248. doi: 10.1128/jcm.34.2.241-248.1996

Synthetic peptide-based enzyme-linked immunosorbent assay for serodiagnosis of visceral leishmaniasis.

C Fargeas 1, M Hommel 1, R Maingon 1, C Dourado 1, M Monsigny 1, R Mayer 1
PMCID: PMC228776  PMID: 8788994

Abstract

Synthetic peptides, derived from the amino acid sequence of a Leishmania donovani clone, were used to develop an enzyme-linked immunosorbent assay (ELISA) for detecting antibodies against L. donovani. For this purpose, five peptides were conjugated to a protein carrier, human serum albumin (HSA), by using a heterobifunctional reagent, epsilon-maleimidocaproic acid N-hydroxysuccinimide ester, to obtain a well-defined product. The sensitivity and the specificity of the peptide-specific ELISA were determined with a panel of 106 serum samples from individuals living in areas where visceral leishmaniasis is endemic; sera from post-kala azar dermal leishmaniasis-infected patients and from individuals suffering from other infectious diseases were also included. ELISAs were performed with either a single peptide-HSA conjugate or a mixture of two peptide-HSA conjugates. Ninety-seven percent of the serum samples from patients with visceral leishmaniasis had detectable antibodies to one or more of the single synthetic peptides. ELISA with a single peptide-HSA conjugate proved to be less sensitive (less than 71%) but more specific (up to 93%) than ELISA with crude promastigote antigens (80% sensitivity and 79% specificity); when a combination of two different peptide-HSA conjugates was used, the test increased both in sensitivity and in specificity. Chemically defined peptide-protein conjugates improve the reproducibility and reliability of ELISA for the serodiagnosis of L. donovani infection.

Full Text

The Full Text of this article is available as a PDF (263.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Avrameas S., Ternynck T. The cross-linking of proteins with glutaraldehyde and its use for the preparation of immunoadsorbents. Immunochemistry. 1969 Jan;6(1):53–66. doi: 10.1016/0019-2791(69)90178-5. [DOI] [PubMed] [Google Scholar]
  2. Badaró R., Jones T. C., Lorenço R., Cerf B. J., Sampaio D., Carvalho E. M., Rocha H., Teixeira R., Johnson W. D., Jr A prospective study of visceral leishmaniasis in an endemic area of Brazil. J Infect Dis. 1986 Oct;154(4):639–649. doi: 10.1093/infdis/154.4.639. [DOI] [PubMed] [Google Scholar]
  3. Badaró R., Reed S. G., Barral A., Orge G., Jones T. C. Evaluation of the micro enzyme-linked immunosorbent assay (ELISA) for antibodies in American visceral leishmaniasis: antigen selection for detection of infection-specific responses. Am J Trop Med Hyg. 1986 Jan;35(1):72–78. doi: 10.4269/ajtmh.1986.35.72. [DOI] [PubMed] [Google Scholar]
  4. Badaró R., Reed S. G., Carvalho E. M. Immunofluorescent antibody test in American visceral leishmaniasis: sensitivity and specificity of different morphological forms of two Leishmania species. Am J Trop Med Hyg. 1983 May;32(3):480–484. doi: 10.4269/ajtmh.1983.32.480. [DOI] [PubMed] [Google Scholar]
  5. Basu D., Mallik K. K., Bhattacharya A., Ghosh A. K. Fluorescent antibody titres after recovery from visceral leishmaniasis. Acta Trop. 1991 Nov;50(1):87–88. doi: 10.1016/0001-706x(91)90076-v. [DOI] [PubMed] [Google Scholar]
  6. Berens R. L., Brun R., Krassner S. M. A simple monophasic medium for axenic culture of hemoflagellates. J Parasitol. 1976 Jun;62(3):360–365. [PubMed] [Google Scholar]
  7. Bouvier J., Etges R., Bordier C. Identification of the promastigote surface protease in seven species of Leishmania. Mol Biochem Parasitol. 1987 May;24(1):73–79. doi: 10.1016/0166-6851(87)90117-4. [DOI] [PubMed] [Google Scholar]
  8. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  9. Briand J. P., Muller S., Van Regenmortel M. H. Synthetic peptides as antigens: pitfalls of conjugation methods. J Immunol Methods. 1985 Apr 8;78(1):59–69. doi: 10.1016/0022-1759(85)90329-1. [DOI] [PubMed] [Google Scholar]
  10. Burns J. M., Jr, Shreffler W. G., Benson D. R., Ghalib H. W., Badaro R., Reed S. G. Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis. Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):775–779. doi: 10.1073/pnas.90.2.775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Button L. L., McMaster W. R. Molecular cloning of the major surface antigen of leishmania. J Exp Med. 1988 Feb 1;167(2):724–729. doi: 10.1084/jem.167.2.724. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Camargo M. E., Rebonato C. Cross-reactivity in fluorescence tests for Trypanosoma and Leishmania antibodies. A simple inhibition procedure to ensure specific results. Am J Trop Med Hyg. 1969 Jul;18(4):500–505. doi: 10.4269/ajtmh.1969.18.500. [DOI] [PubMed] [Google Scholar]
  13. Carlsson J., Drevin H., Axén R. Protein thiolation and reversible protein-protein conjugation. N-Succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent. Biochem J. 1978 Sep 1;173(3):723–737. doi: 10.1042/bj1730723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Chowdhury M. S., el Harith A., al Massum A., al Karim E., al Rahman A. Prevalence of agglutinating anti-Leishmania antibodies in two multi-thousand Bengoli communities. Parasitol Res. 1993;79(6):444–450. doi: 10.1007/BF00931580. [DOI] [PubMed] [Google Scholar]
  15. Edrissian G. H., Darabian P. A comparison of enzyme-linked immunosorbent assay and indirect fluorescent antibody test in the sero-diagnosis of cutaneous and visceral leishmaniasis in Iran. Trans R Soc Trop Med Hyg. 1979;73(3):289–292. doi: 10.1016/0035-9203(79)90084-1. [DOI] [PubMed] [Google Scholar]
  16. Guimarães M. C., Celeste B. J., de Castilho E. A., Mineo J. R., Diniz J. M. Immunoenzymatic assy (ELISA) in mucocutaneous leishmaniasis, kala-azar, and Chagas' disease: an epimastigote Trypanosoma cruzi antigen able to distinguish between anti-Trypanosoma and anti-Leishmania antibodies. Am J Trop Med Hyg. 1981 Sep;30(5):942–947. doi: 10.4269/ajtmh.1981.30.942. [DOI] [PubMed] [Google Scholar]
  17. Harith A. E., Kolk A. H., Kager P. A., Leeuwenburg J., Faber F. J., Muigai R., Kiugu S., Laarman J. J. Evaluation of a newly developed direct agglutination test (DAT) for serodiagnosis and sero-epidemiological studies of visceral leishmaniasis: comparison with IFAT and ELISA. Trans R Soc Trop Med Hyg. 1987;81(4):603–606. doi: 10.1016/0035-9203(87)90423-8. [DOI] [PubMed] [Google Scholar]
  18. Harith A. E., Kolk A. H., Kager P. A., Leeuwenburg J., Muigai R., Kiugu S., Kiugu S., Laarman J. J. A simple and economical direct agglutination test for serodiagnosis and sero-epidemiological studies of visceral leishmaniasis. Trans R Soc Trop Med Hyg. 1986;80(4):583–536. doi: 10.1016/0035-9203(86)90149-5. [DOI] [PubMed] [Google Scholar]
  19. Hommel M., Peters W., Ranque J., Quilici M., Lanotte G. The micro-ELISA technique in the serodiagnosis of visceral leishmaniasis. Ann Trop Med Parasitol. 1978 Jun;72(3):213–218. doi: 10.1080/00034983.1978.11719308. [DOI] [PubMed] [Google Scholar]
  20. Hopp T. P., Woods K. R. Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci U S A. 1981 Jun;78(6):3824–3828. doi: 10.1073/pnas.78.6.3824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Jaffe C. L., Zalis M. Use of purified parasite proteins from Leishmania donovani for the rapid serodiagnosis of visceral leishmaniasis. J Infect Dis. 1988 Jun;157(6):1212–1220. doi: 10.1093/infdis/157.6.1212. [DOI] [PubMed] [Google Scholar]
  22. Kager P. A. Visceral leishmaniasis in The Netherlands. Neth J Med. 1985;28(10):477–481. [PubMed] [Google Scholar]
  23. Kanda P., Kennedy R. C., Sparrow J. T. Synthesis of polyamide supports for use in peptide synthesis and as peptide-resin conjugates for antibody production. Int J Pept Protein Res. 1991 Oct;38(4):385–391. doi: 10.1111/j.1399-3011.1991.tb01518.x. [DOI] [PubMed] [Google Scholar]
  24. Kyte J., Doolittle R. F. A simple method for displaying the hydropathic character of a protein. J Mol Biol. 1982 May 5;157(1):105–132. doi: 10.1016/0022-2836(82)90515-0. [DOI] [PubMed] [Google Scholar]
  25. Lainson R. The American leishmaniases: some observations on their ecology and epidemiology. Trans R Soc Trop Med Hyg. 1983;77(5):569–596. doi: 10.1016/0035-9203(83)90185-2. [DOI] [PubMed] [Google Scholar]
  26. Lee A. C., Powell J. E., Tregear G. W., Niall H. D., Stevens V. C. A method for preparing beta-hCG COOH peptide-carrier conjugates of predictable composition. Mol Immunol. 1980 Jun;17(6):749–756. doi: 10.1016/0161-5890(80)90145-5. [DOI] [PubMed] [Google Scholar]
  27. Medrano F. J., Hernández-Quero J., Jiménez E., Pineda J. A., Rivero A., Sánchez-Quijano A., Velez I. D., Viciana P., Castillo R., Reyes M. J. Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain? AIDS. 1992 Dec;6(12):1499–1503. doi: 10.1097/00002030-199212000-00013. [DOI] [PubMed] [Google Scholar]
  28. Okong'o-Odera E. A., Wamachi A., Kagai J. M., Kurtzhals J. A., Githure J. I., Hey A. S., Were J. B., Koech D. K., Mitema E. S., Kharazmi A. Field application of an ELISA using redefined Leishmania antigens for the detection of visceral leishmaniasis. Trans R Soc Trop Med Hyg. 1993 Jul-Aug;87(4):423–424. doi: 10.1016/0035-9203(93)90023-j. [DOI] [PubMed] [Google Scholar]
  29. Pal A., Mukerji K., Basu D., Naskar K., Mallick K. K., Ghosh D. K. Evaluation of direct agglutination test (DAT) and ELISA for serodiagnosis of visceral leishmaniasis in India. J Clin Lab Anal. 1991;5(5):303–306. doi: 10.1002/jcla.1860050502. [DOI] [PubMed] [Google Scholar]
  30. Pappas M. G., Hajkowski R., Hockmeyer W. T. Dot enzyme-linked immunosorbent assay (Dot-ELISA): a micro technique for the rapid diagnosis of visceral leishmaniasis. J Immunol Methods. 1983 Nov 11;64(1-2):205–214. doi: 10.1016/0022-1759(83)90399-x. [DOI] [PubMed] [Google Scholar]
  31. Peralta J. M., Teixeira M. G., Shreffler W. G., Pereira J. B., Burns J. M., Jr, Sleath P. R., Reed S. G. Serodiagnosis of Chagas' disease by enzyme-linked immunosorbent assay using two synthetic peptides as antigens. J Clin Microbiol. 1994 Apr;32(4):971–974. doi: 10.1128/jcm.32.4.971-974.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Perea W. A., Moren A., Ancelle T., Sondorp E. Epidemic visceral leishmaniasis in southern Sudan. Lancet. 1989 Nov 18;2(8673):1222–1223. doi: 10.1016/s0140-6736(89)91834-5. [DOI] [PubMed] [Google Scholar]
  33. Piarroux R., Gambarelli F., Dumon H., Fontes M., Dunan S., Mary C., Toga B., Quilici M. Comparison of PCR with direct examination of bone marrow aspiration, myeloculture, and serology for diagnosis of visceral Leishmaniasis in immunocompromised patients. J Clin Microbiol. 1994 Mar;32(3):746–749. doi: 10.1128/jcm.32.3.746-749.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Reichlin M. Use of glutaraldehyde as a coupling agent for proteins and peptides. Methods Enzymol. 1980;70(A):159–165. doi: 10.1016/s0076-6879(80)70047-2. [DOI] [PubMed] [Google Scholar]
  35. Rosenthal E., Marty P., Poizot-Martin I., Reynes J., Pratlong F., Lafeuillade A., Jaubert D., Boulat O., Dereure J., Gambarelli F. Visceral leishmaniasis and HIV-1 co-infection in southern France. Trans R Soc Trop Med Hyg. 1995 Mar-Apr;89(2):159–162. doi: 10.1016/0035-9203(95)90476-x. [DOI] [PubMed] [Google Scholar]
  36. Shreffler W. G., Burns J. M., Jr, Badaró R., Ghalib H. W., Button L. L., McMaster W. R., Reed S. G. Antibody responses of visceral leishmaniasis patients to gp63, a major surface glycoprotein of Leishmania species. J Infect Dis. 1993 Feb;167(2):426–430. doi: 10.1093/infdis/167.2.426. [DOI] [PubMed] [Google Scholar]
  37. Vergara U., Veloso C., Gonzalez A., Lorca M. Evaluation of an enzyme-linked immunosorbent assay for the diagnosis of Chagas' disease using synthetic peptides. Am J Trop Med Hyg. 1992 Jan;46(1):39–43. doi: 10.4269/ajtmh.1992.46.39. [DOI] [PubMed] [Google Scholar]
  38. Xu Z. B., Xiong J., You J. Y., Zhong H. L., Chen W. K., Zhao E. M., Jiao L. E., Li J. S. Micro-enzyme-linked-immunosorbent assay in diagnosis of kala-azar. Chin Med J (Engl) 1982 Sep;95(9):649–652. [PubMed] [Google Scholar]
  39. Yolken R. H. Enzyme-linked immunosorbent assay (ELISA): a practical tool for rapid diagnosis of viruses and other infectious agents. Yale J Biol Med. 1980 Jan-Feb;53(1):85–92. [PMC free article] [PubMed] [Google Scholar]
  40. Zijlstra E. E., Ali M. S., el-Hassan A. M., el-Toum I. A., Satti M., Ghalib H. W., Kager P. A. Kala-azar: a comparative study of parasitological methods and the direct agglutination test in diagnosis. Trans R Soc Trop Med Hyg. 1992 Sep-Oct;86(5):505–507. doi: 10.1016/0035-9203(92)90086-r. [DOI] [PubMed] [Google Scholar]
  41. el Safi S. H., Evans D. A. A comparison of the direct agglutination test and enzyme-linked immunosorbent assay in the sero-diagnosis of leishmaniasis in the Sudan. Trans R Soc Trop Med Hyg. 1989 May-Jun;83(3):334–337. doi: 10.1016/0035-9203(89)90493-8. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES